1. p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models
- Author
-
Paula Stein, Russell J. Butterfield, Carmen J. Williams, Roberta Menafra, Christina M. Smith, Jingtao Guo, Peter G. Hendrickson, Bradley D. Weaver, Nicholas E. Johnson, Bradley R. Cairns, Susan L. Kloet, Edward J. Grow, Silvère M. van der Maarel, and Sean C. Shadle
- Subjects
Pluripotent Stem Cells ,Cell type ,Zygote ,Biology ,Article ,Mice ,DUX4 ,Genetics ,medicine ,Animals ,Humans ,Facioscapulohumeral muscular dystrophy ,Muscular dystrophy ,Homeodomain Proteins ,Mice, Knockout ,Gene Expression Regulation, Developmental ,Nuclear Proteins ,Cell Differentiation ,Mouse Embryonic Stem Cells ,Cellular Reprogramming ,medicine.disease ,Embryonic stem cell ,Muscular Dystrophy, Facioscapulohumeral ,Chromatin ,Cell biology ,Maternal to zygotic transition ,Tumor Suppressor Protein p53 ,Stem cell ,DNA Damage ,Transcription Factors - Abstract
In mammalian embryos, proper zygotic genome activation (ZGA) underlies totipotent development. Double homeobox (DUX)-family factors participate in ZGA, and mouse Dux is required for forming cultured two-cell (2C)-like cells. Remarkably, in mouse embryonic stem cells, Dux is activated by the tumor suppressor p53, and Dux expression promotes differentiation into expanded-fate cell types. Long-read sequencing and assembly of the mouse Dux locus reveals its complex chromatin regulation including putative positive and negative feedback loops. We show that the p53–DUX/DUX4 regulatory axis is conserved in humans. Furthermore, we demonstrate that cells derived from patients with facioscapulohumeral muscular dystrophy (FSHD) activate human DUX4 during p53 signaling via a p53-binding site in a primate-specific subtelomeric long terminal repeat (LTR)10C element. In summary, our work shows that p53 activation convergently evolved to couple p53 to Dux/DUX4 activation in embryonic stem cells, embryos and cells from patients with FSHD, potentially uniting the developmental and disease regulation of DUX-family factors and identifying evidence-based therapeutic opportunities for FSHD. p53 activates Dux in mouse embryos and embryonic stem cells, as well as DUX4 in human facioscapulohumeral muscular dystrophy cell models.
- Published
- 2021
- Full Text
- View/download PDF